Kidney-pancreas transplantation in a long-term non-progressor HIV-infected recipient

American Journal of Transplantation

Volumn 3, Issue 5, 2003, Pages 631-633

  Toso, Christian ^a   Berney, Thierry ^a   Oberholzer, José ^a   Chave, Jean Philippe ^b   Martin, Pierre Yves ^a   Zeender, Eve ^a   Bosco, Domenico ^a   Morel, Philippe ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

HIV; Kidney; Long term non progressor; Pancreas; Transplantation

Indexed keywords

BASILIXIMAB; CEFTRIAXONE; COTRIMOXAZOLE; FLUCONAZOLE; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; GRAFT REJECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE INFECTION; RECIPIENT;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PANCREAS TRANSPLANTATION; PANCREATIC DISEASES; RECEPTORS, CCR5; TIME FACTORS;

EID: 0038585103     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00119.x     Document Type: Article

References (21)

1. Gow PJ, Pillay D, Mutimer D. Solid organ transplantation in patients with HIV infection. Transplantation 2001; 72 (2): 177-181.
2. Kuo PC Stock PG. Transplantation in the HIV+ patient. Am J Transplant 2001; 1 (1): 13-17
3. Srinivasan P, Muiesan P, Wendon J et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 27 (10): 1684-1688.
4. Wuthrich RP, Rothenpieler U, Schneeberger H et al. CC chemokine receptor 5 and renal-transplant survival. The Lancet 2001; 357: 1758-1761.
5. Tzakis AG, Cooper MH, Dummer JS, Ragni M, Ward JW, Starzl TE. Transplantation in HIV+ patients. Transplantation 1990; 49 (2): 354-358.
6. Erice A, Rhame FS, Heussner RC, Dunn DL, Balfour HH. Human immunodeficiency virus infection in patients with solid-organ transplants, report of five cases and review. Rev Inf Dis 1991; 13: 537-547.
7. Simonds RJ. HIV transmission by organ and tissue transplantation. AIDS 1993; 7: S35-S8.
8. Gootenberg JE, Stewart CL, Vetro SW, Bellanti JA. Lack of graft rejection in a renal transplant patient with HIV. Ann Allergy 1991; 67: 123-125.
9. Bouscarat F, Samuel D, Simon F, Debat P, Bismuth H, Saimot AG. An observational study of 11 French liver transplant recipients infected with Human Immunodeficiency Virus type I. Clin Infect Dis 1994; 19: 854-859.
10. Ahuja TA, Zingman B, Glicklich D. Long term survival in an HIV-infected renal transplant recipient. Am J Nephrology 1997; 17: 480-482.
11. Spire B, George F, Robert A et al. Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient. Transplantation 1998; 66 (10): 1384-1386.
12. Freise C, Hirose R, Terrault N et al. Solid organ transplantation in HIV-positive patients. Transpl Proc 2001; 33: 3646-3648.
13. Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002; 347 (4): 284-287.
14. Neff GW, Jayaweera D, Tzakis AG. Liver transplantation for HIV-infected patients with end-stage liver disease. Curr Opin Organ Transplant 2002; 7: 114-123.
15. Scantlebury VP, Potdar S, Bonham CA et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 2002; 8 (9): 841-845.
16. Attinger A, Knabenhans C, Fleury S et al. Effects of mycophenolate acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 2000; 6 (7): 762-768.
17. Coombs RW, Fox L, Schock B et al. Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation. J Acquir Immune Defic Syndr 2002; 29 (4): 356-362.
18. Karpas A, Lowdell M, Jacobson SK, Hill F. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK506. Proc Natl Acad Sci U S A 1992; 89 (17): 8351-8355.
19. Briggs CJ, Ott DE, Coren LV, Oroszlan S, Tozser J. Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1. Arch Virol 1999; 144 (11): 2151-2160.
20. Roy J, Paquette JS, Fortin JF, Tremblay MJ. The immunosuppressant rapamycin represses human immunodeficiency virus type I replication. Antimicrob Agents Chemother 2002; 46 (11): 3447-3455.
21. Huttley GA, Smith MW, Allikmets R et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structure gene. Hemophilia growth and development study, Multicenter AIDS cohort study, Multicenter hemophilia cohort study, San Francisco city cohort, ALIVE study. Science 1996; 273 (5283): 1856-1862.